| Literature DB >> 35013163 |
Álvaro Andreu-Bernabeu1,2, Javier González-Peñas3,4,5, Covadonga M Díaz-Caneja1,2,6,7, Javier Costas8, Lucía De Hoyos1,2, Carol Stella1,2, Xaquín Gurriarán1,2,8, Clara Alloza1,2, Lourdes Fañanás6,9, Julio Bobes6,10, Ana González-Pinto6,11, Benedicto Crespo-Facorro6,12, Lourdes Martorell6,13, Elisabet Vilella6,13, Gerard Muntané6,13, Juan Nacher6,14, María Dolores Molto6,15,16, Eduardo Jesús Aguilar6,16,17, Mara Parellada1,2,6,7, Celso Arango1,2,6,7.
Abstract
Previous research suggests an association of loneliness and social isolation (LNL-ISO) with schizophrenia. Here, we demonstrate a LNL-ISO polygenic score contribution to schizophrenia risk in an independent case-control sample (N = 3,488). We then subset schizophrenia predisposing variation based on its effect on LNL-ISO. We find that genetic variation with concordant effects in both phenotypes shows significant SNP-based heritability enrichment, higher polygenic contribution in females, and positive covariance with mental disorders such as depression, anxiety, attention-deficit hyperactivity disorder, alcohol dependence, and autism. Conversely, genetic variation with discordant effects only contributes to schizophrenia risk in males and is negatively correlated with those disorders. Mendelian randomization analyses demonstrate a plausible bi-directional causal relationship between LNL-ISO and schizophrenia, with a greater effect of LNL-ISO liability on schizophrenia than vice versa. These results illustrate the genetic footprint of LNL-ISO on schizophrenia.Entities:
Mesh:
Year: 2022 PMID: 35013163 PMCID: PMC8748758 DOI: 10.1038/s41467-021-27598-6
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694
Fig. 1Workflow of the analytic pipeline.
GWAS summary statistics from schizophrenia[83] and LNL-ISO[32] were used. We evaluated the LNL-ISO polygenic score (PGSLNL-ISO) contribution to schizophrenia risk in an independent case-control sample (NSCZ = 1927; NHC = 1561). Subsequent genomic dissection of schizophrenia GWAS based on LNL-ISO led to different annotations: (i) SCZ[LNL]: variants from the schizophrenia GWAS associated with LNL-ISO (PLNL-ISO < 0.05), (ii) SCZ[CONC]: variants from the schizophrenia GWAS associated with LNL-ISO (PLNL-ISO < 0.05) and concordant allele effects in both phenotypes (BetaSCZ > 0 & BetaLNL-ISO > 0 OR BetaSCZ < 0 & BetaLNL-ISO < 0), and (iii) SCZ[DISC]: variants from the schizophrenia GWAS associated with LNL-ISO (PLNL-ISO < 0.05) and discordant allele effects in both phenotypes (BetaSCZ > 0 & BetaLNL-ISO < 0 OR BetaSCZ < 0 & BetaLNL-ISO > 0), and (iv) (SCZ[noLNL]: variants from the schizophrenia GWAS not associated with LNL-ISO (PLNL-ISO > 0.05); see Methods and Supplementary Methods for further details). We performed PGS analyses, partitioned heritability, and annotation-based stratified genetic covariance analyses across those subsets. We performed Mendelian randomization to evaluate causality between schizophrenia and LNL-ISO (and its constituent traits). “+” and “−” in the figure refer to the direction of the effect of the alleles studied.
Fig. 2Polygenic score contribution of LNL-ISO (PGSLNL-ISO) and schizophrenia (PGSSCZ) to schizophrenia risk and heritability estimates.
A PGS predictions of LNL-ISO (PGSLNL-ISO) and its constituent phenotypes (see legend) on an independent schizophrenia case-control sample (NSCZ = 1927; NHC = 1561). Explained variance attributable to PGS was calculated as the increase in Nagelkerke’s pseudo-R2 between a linear model with and without the PGS variable. P-values were obtained from the binomial logistic regression of SCZ phenotype on PGS, accounting for Linkage Disequilibrium (LD) and including sex, age, and ten multidimensional scalings (MDS) ancestry components as covariates. Significant PGS predictions after FDR correction (p < 0.05) are marked with an asterisk. See Supplementary Fig. 1 for R2 values for PGS predictions on the liability scale estimated using UK Biobank prevalence for LNL-ISO constituent phenotypes. For a full detailed description and results see Supplementary Methods 3 and Supplementary Data 1. B PGS predictions of schizophrenia (PGSSCZ) on an independent schizophrenia case-control sample (NSCZ = 1927; NHC = 1561). We used schizophrenia GWAS summary statistics overlapping with LNL-ISO summary statistics (SCZ(ALL)) and three subsets of them based on their effects on LNL-ISO: variants not associated with LNL-ISO (SCZ[noLNL]) and those associated with LNL-ISO with either concordant (SCZ[CONC]) or discordant (SCZ[DISC]) allele effects in each trait. Explained variance attributable to PGS was calculated as the increase in Nagelkerke’s pseudo-R2 between a linear model with and without the PGS variable. Pseudo-R2 was converted to liability scale following the procedure proposed by Lee et al.[85] assuming a prevalence of schizophrenia in the general population of 1%[86]. P-values were obtained from the binomial logistic regression of SCZ phenotype on PGS, accounting for LD and including sex, age, and ten MDS ancestry components as covariates. Significant PGS predictions after FDR correction (p < 0.05) are marked with an asterisk. For a full detailed description and results see Supplementary Methods 4 and Supplementary Data 2 A. C Quantile plot of PGSSCZ predictions from the partitions described in B. The target sample is separated into deciles of increasing PGSSCZ. The case-control status of each decile is compared to the median (5th decile), one by one, using a logistic regression model with covariates (sex, age, and ten MDS ancestry components). OR values for each comparison were estimated from regression coefficients of these decile-status predictors. Significant comparisons (p < 0.05) are marked with an asterisk. For a full detailed description and results see Supplementary Methods 4 and Supplementary Data 2B. D Proportion of SNP-based heritability (h) and heritability enrichment (h/N) of the annotations in schizophrenia were estimated by LD-score regression (LDSR). 95% confidence intervals based on standard errors are shown for each estimate (estimation +/− 1.96*SE). p-values and standard errors were calculated using a block jackknife procedure. See Supplementary Data 3 for the significance of each enrichment estimate.
Fig. 3Density plot for sex comparison of PGSSCZ contributions to schizophrenia risk.
PGSSCZ predictions in case-control subsamples after bootstrap resampling (5000 permutations) of 500 schizophrenia patients (SCZ) and 500 healthy controls (HC) (selected from the overall CIBERSAM case-control sample) were performed in males (NSCZ = 1253; NHC = 859) and females (NSCZ = 674; NHC = 702), separately. Mean SCZ-HC variance explained by PGSSCZ on the liability scale (estimated prevalence of 0.01) in males and females was compared for predisposing variation within genome partitions. Variance explained in females and males was statistically compared with two-sided t-tests and is marked with an asterisk when it is significantly different (p < 0.05). A PGSSCZ predictions comparison from variants within SCZ[noLNL]. B PGSSCZ predictions comparison from variants within SCZ[LNL]. C PGSSCZ predictions comparison from variants within SCZ[CONC]. D PGSSCZ predictions comparison from variants within SCZ[DISC].
Fig. 4Annotation-stratified genetic covariance between schizophrenia and related traits.
We calculated covariances with GNOVA within SNP subsets from SCZ[noLNL], SCZ[CONC], and SCZ[DISC] annotations. P-values were calculated for the genetic covariance based on two-sided Wald tests. Error bars represent 95% confidence intervals based on standard errors (covariance estimation + /− 1.96*SE). FDR-corrected significant associations (p < 0.05) are marked with an asterisk. Traits and disorders are abbreviated as follows: major depression (MDD), attention and deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), anxiety disorder (ANX), bipolar disorder (BIP), obsessive-compulsive disorder (OCD), alcohol dependence disorder (ALC-DEP), cross-disorder phenotype (CROSS-DIS), neuroticism (NEUR), depressive symptoms (DS), subjective well-being (SWB), psychotic experiences in the general population (PSY-EXP), educational attainment (EA), and body mass index (BMI). For further details of the phenotypes see Supplementary Data 6 and Supplementary Methods 6.
Bidirectional causal inference analyses between loneliness and isolation phenotypes and schizophrenia.
| Causal Effects of Loneliness and Isolation related traits on Schizophrenia | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposure | Number of Instruments | Outcome | IVW | Weighted Median | MR-Egger | Heterogeneity | MR-Egger Intercept | MR-PRESSO | CAUSE | ||||||
| β (SE) | β (SE) | β (SE) | Outliers ( | β (Sd) | γ (CI95%) | ||||||||||
| 13 | Schizophrenia | 1.114 (0.48) | 0.021 | −1.112 (2.36) | 0.646 | 2.94E-06 | 0.36 | 3 | |||||||
| 14 | Schizophrenia | 1.366 (1.23) | 0.260 | 3.797 (6.01) | 0.538 | 8.00E-07 | 0.68 | 2 | |||||||
| Friends/Family visits | 19 | Schizophrenia | 0.486 (0.31) | 0.13 | 0.446 (0.25) | 0.08 | 2.511 (1.69) | 0.156 | 2.20E-06 | 0.24 | 2 | 0.524 (0.19) | 0.015 | 0.21 (0. 0.43) | 0.210 |
| Number in household* | 15 | Schizophrenia | −0.699 (0.71) | 0.32 | −0.174 (0.57) | 0.76 | −0.619 (3.03) | 0.841 | 1.6E-06 | 0.97 | 2 | −0.574 (0.48) | 0.25 | −1.09 (−2.19. 0.01) | 0.220 |
| 12 | Schizophrenia | − | − | −0.667 (1.09) | 0.554 | 3.50E-04 | 0.96 | 2 | − | −0.19 (−0.33. −0.05) | 0.065 | ||||
| Schizophrenia | 69 | 0.012 (0.005) | 0.020 | 0.026 (0.02) | 0.190 | 2.21E-11 | 0.48 | 2 | |||||||
| Schizophrenia | 69 | 0.004 (0.002) | 0.067 | 0.010 (0.008) | 0.230 | 6.92E-16 | 0.47 | 3 | 0.004 (0.002) | 0.025 | |||||
| Schizophrenia | 69 | Friends/Family visits | 0.005 (0.007) | 0.458 | 0.007 (0.007) | 0.33 | 0.005 (0.025) | 0.826 | 1.53E-17 | 0.99 | 2 | 0.008 (0.006) | 0.165 | 0 (0. 0.01) | 0.220 |
| Schizophrenia | 69 | − | − | −0.003 (0.011) | 0.788 | 3.12E-03 | 0.63 | 2 | −0.006 (0.002) | 0.021 | −0.01 (−0.01. 0) | 0.025 | |||
| Schizophrenia | 69 | Able to confide | −0.012 (0.009) | 0.184 | −0.017 (0.003) | 0.09 | −0.014 (0.03) | 0.68 | 1.53E-05 | 0.95 | NA | −0.012 (0.009) | 0.188 | −0.01 (−0.02. 0) | 0.032 |
Traits in bold have significant results in at least one method after Benjamini–Hochberg FDR correction. Effect sizes and P-values labelled in bold are significant after Benjamini–Hochberg FDR correction (P < 0.05). *We selected genome-wide significant SNPs as Instrumental Variables at p < 5 × 10−8 for all the traits except for “Number of people in household” due to a lower number of significant SNPs at that threshold. For this trait, we used a threshold of p < 5 × 10−6 instead. The column “Outliers” reports the number of pleiotropic variants removed with MR-PRESSO. MR-PRESSO β-Effects were estimated after removing the outliers. IVW, inverse variance weighted linear regression. SE, Standard error measure of effect size. Q-P-Value, P-value of IVW Cochran′s Q statistic. LNL-ISO MTAG, Multi-trait GWAS of loneliness and social isolation. Loneliness UKBB, loneliness trait from the UK Biobank. Friends/family visit, UK Biobank trait of frequency of friends/family visits. Able to confide, UK Biobank trait of frequency of confide in someone close to you. γ (CI95%) Posterior median and 95% credible intervals of the true value of causal effect with CAUSE. P (CAUSE): p-value testing that causal model is better than sharing model using ELPD test (significance level p < 0.05).